APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pets Parasiticide Medicines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pets Parasiticide Medicines Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchPets Parasiticide Medicines Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Pets Parasiticide Medicines Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Pets Parasiticide Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pets Parasiticide Medicines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pets Parasiticide Medicines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pets Parasiticide Medicines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pets Parasiticide Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pets Parasiticide Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pets Parasiticide Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pets Parasiticide Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pets Parasiticide Medicines include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Vetoquinol, Virbac, Zoetis, Bayer and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pets Parasiticide Medicines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pets Parasiticide Medicines, also provides the revenue of main regions and countries. Of the upcoming market potential for Pets Parasiticide Medicines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pets Parasiticide Medicines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pets Parasiticide Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pets Parasiticide Medicines revenue, projected growth trends, production technology, application and end-user industry.

Pets Parasiticide Medicines Segment by Company

Bimeda Animal Health

Boehringer Ingelheim

Ceva Sante Animale

Elanco

Vetoquinol

Virbac

Zoetis

Bayer

Merck

Pets Parasiticide Medicines Segment by Type

In Vitro Parasiticide Medicines

In Vivo Parasiticide Medicines

Pets Parasiticide Medicines Segment by Application

Cats

Equine

Dogs

Others

Pets Parasiticide Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Parasiticide Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pets Parasiticide Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Parasiticide Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pets Parasiticide Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pets Parasiticide Medicines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pets Parasiticide Medicines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pets Parasiticide Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. In Vitro Parasiticide Medicines Major Player Table 3. In Vivo Parasiticide Medicines Major Player Table 4. Global Pets Parasiticide Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cats Major Player Table 6. Equine Major Player Table 7. Dogs Major Player Table 8. Others Major Player Table 9. Pets Parasiticide Medicines Industry Trends Table 10. Pets Parasiticide Medicines Industry Drivers Table 11. Pets Parasiticide Medicines Industry Opportunities and Challenges Table 12. Pets Parasiticide Medicines Industry Restraints Table 13. Global Pets Parasiticide Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pets Parasiticide Medicines Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pets Parasiticide Medicines Market Share by Region (2021-2026) Table 16. Global Pets Parasiticide Medicines Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pets Parasiticide Medicines Market Share by Region (2027-2032) Table 18. Global Pets Parasiticide Medicines Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pets Parasiticide Medicines Revenue Market Share by Players (2021-2026) Table 20. Global Pets Parasiticide Medicines Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pets Parasiticide Medicines Key Players Headquarters & Area Served Table 22. Global Pets Parasiticide Medicines Players, Product Type & Application Table 23. Global Pets Parasiticide Medicines Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pets Parasiticide Medicines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pets Parasiticide Medicines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pets Parasiticide Medicines Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pets Parasiticide Medicines Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pets Parasiticide Medicines Revenue Market Share by Type (2021-2026) Table 30. Global Pets Parasiticide Medicines Revenue Market Share by Type (2027-2032) Table 31. Global Pets Parasiticide Medicines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pets Parasiticide Medicines Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pets Parasiticide Medicines Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pets Parasiticide Medicines Revenue Market Share by Application (2021-2026) Table 35. Global Pets Parasiticide Medicines Revenue Market Share by Application (2027-2032) Table 36. Bimeda Animal Health Company Information Table 37. Bimeda Animal Health Business Overview Table 38. Bimeda Animal Health Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Bimeda Animal Health Pets Parasiticide Medicines Product Portfolio Table 40. Bimeda Animal Health Recent Development Table 41. Boehringer Ingelheim Company Information Table 42. Boehringer Ingelheim Business Overview Table 43. Boehringer Ingelheim Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Boehringer Ingelheim Pets Parasiticide Medicines Product Portfolio Table 45. Boehringer Ingelheim Recent Development Table 46. Ceva Sante Animale Company Information Table 47. Ceva Sante Animale Business Overview Table 48. Ceva Sante Animale Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Ceva Sante Animale Pets Parasiticide Medicines Product Portfolio Table 50. Ceva Sante Animale Recent Development Table 51. Elanco Company Information Table 52. Elanco Business Overview Table 53. Elanco Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Elanco Pets Parasiticide Medicines Product Portfolio Table 55. Elanco Recent Development Table 56. Vetoquinol Company Information Table 57. Vetoquinol Business Overview Table 58. Vetoquinol Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Vetoquinol Pets Parasiticide Medicines Product Portfolio Table 60. Vetoquinol Recent Development Table 61. Virbac Company Information Table 62. Virbac Business Overview Table 63. Virbac Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Virbac Pets Parasiticide Medicines Product Portfolio Table 65. Virbac Recent Development Table 66. Zoetis Company Information Table 67. Zoetis Business Overview Table 68. Zoetis Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Zoetis Pets Parasiticide Medicines Product Portfolio Table 70. Zoetis Recent Development Table 71. Bayer Company Information Table 72. Bayer Business Overview Table 73. Bayer Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Bayer Pets Parasiticide Medicines Product Portfolio Table 75. Bayer Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Pets Parasiticide Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Merck Pets Parasiticide Medicines Product Portfolio Table 80. Merck Recent Development Table 81. North America Pets Parasiticide Medicines Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Pets Parasiticide Medicines Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Pets Parasiticide Medicines Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Pets Parasiticide Medicines Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Pets Parasiticide Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Pets Parasiticide Medicines Revenue by Country (2021-2026) & (US$ Million) Table 87. North America Pets Parasiticide Medicines Revenue by Country (US$ Million) & (2027-2032) Table 88. Europe Pets Parasiticide Medicines Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Pets Parasiticide Medicines Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Pets Parasiticide Medicines Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Pets Parasiticide Medicines Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Pets Parasiticide Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Pets Parasiticide Medicines Revenue by Country (2021-2026) & (US$ Million) Table 94. Europe Pets Parasiticide Medicines Revenue by Country (US$ Million) & (2027-2032) Table 95. China Pets Parasiticide Medicines Revenue by Type (2021-2026) & (US$ Million) Table 96. China Pets Parasiticide Medicines Revenue by Type (2027-2032) & (US$ Million) Table 97. China Pets Parasiticide Medicines Revenue by Application (2021-2026) & (US$ Million) Table 98. China Pets Parasiticide Medicines Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Pets Parasiticide Medicines Revenue by Type (2021-2026) & (US$ Million) Table 100. Asia Pets Parasiticide Medicines Revenue by Type (2027-2032) & (US$ Million) Table 101. Asia Pets Parasiticide Medicines Revenue by Application (2021-2026) & (US$ Million) Table 102. Asia Pets Parasiticide Medicines Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Pets Parasiticide Medicines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Pets Parasiticide Medicines Revenue by Region (US$ Million) & (2021-2026) Table 105. Asia Pets Parasiticide Medicines Revenue by Region (US$ Million) & (2027-2032) Table 106. SAMEA Pets Parasiticide Medicines Revenue by Type (2021-2026) & (US$ Million) Table 107. SAMEA Pets Parasiticide Medicines Revenue by Type (2027-2032) & (US$ Million) Table 108. SAMEA Pets Parasiticide Medicines Revenue by Application (2021-2026) & (US$ Million) Table 109. SAMEA Pets Parasiticide Medicines Revenue by Application (2027-2032) & (US$ Million) Table 110. SAMEA Pets Parasiticide Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. SAMEA Pets Parasiticide Medicines Revenue by Country (2021-2026) & (US$ Million) Table 112. SAMEA Pets Parasiticide Medicines Revenue by Country (US$ Million) & (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Pets Parasiticide Medicines Image Figure 2. Global Pets Parasiticide Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pets Parasiticide Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 4. In Vitro Parasiticide Medicines Image Figure 5. In Vivo Parasiticide Medicines Image Figure 6. Global Pets Parasiticide Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pets Parasiticide Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cats Image Figure 9. Equine Image Figure 10. Dogs Image Figure 11. Others Image Figure 12. Global Pets Parasiticide Medicines Market Size (US$ Million) & (2021-2032) Figure 13. Global Pets Parasiticide Medicines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pets Parasiticide Medicines Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pets Parasiticide Medicines Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pets Parasiticide Medicines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pets Parasiticide Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pets Parasiticide Medicines Revenue Market Share by Type (2021-2032) Figure 20. Global Pets Parasiticide Medicines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pets Parasiticide Medicines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pets Parasiticide Medicines Revenue Market Share by Application (2021-2032) Figure 23. North America Pets Parasiticide Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pets Parasiticide Medicines Revenue Share by Type (2021-2032) Figure 25. North America Pets Parasiticide Medicines Revenue Share by Application (2021-2032) Figure 26. North America Pets Parasiticide Medicines Revenue Share by Country (2021-2032) Figure 27. United States Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pets Parasiticide Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pets Parasiticide Medicines Revenue Share by Type (2021-2032) Figure 32. Europe Pets Parasiticide Medicines Revenue Share by Application (2021-2032) Figure 33. Europe Pets Parasiticide Medicines Revenue Share by Country (2021-2032) Figure 34. Germany Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pets Parasiticide Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pets Parasiticide Medicines Revenue Share by Type (2021-2032) Figure 44. China Pets Parasiticide Medicines Revenue Share by Application (2021-2032) Figure 45. Asia Pets Parasiticide Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pets Parasiticide Medicines Revenue Share by Type (2021-2032) Figure 47. Asia Pets Parasiticide Medicines Revenue Share by Application (2021-2032) Figure 48. Asia Pets Parasiticide Medicines Revenue Share by Region (2021-2032) Figure 49. Japan Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pets Parasiticide Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pets Parasiticide Medicines Revenue Share by Type (2021-2032) Figure 57. SAMEA Pets Parasiticide Medicines Revenue Share by Application (2021-2032) Figure 58. SAMEA Pets Parasiticide Medicines Revenue Share by Country (2021-2032) Figure 59. Brazil Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pets Parasiticide Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro Parasiticide Medicines
  • In Vivo Parasiticide Medicines
Applications
  • Cats
  • Equine
  • Dogs
  • Others
Companies covered
  • Bimeda Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Elanco
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pets Parasiticide Medicines Market by Type
  3. 1.2.1 Global Pets Parasiticide Medicines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 In Vitro Parasiticide Medicines
  5. 1.2.3 In Vivo Parasiticide Medicines
  6. 1.3 Pets Parasiticide Medicines Market by Application
  7. 1.3.1 Global Pets Parasiticide Medicines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cats
  9. 1.3.3 Equine
  10. 1.3.4 Dogs
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pets Parasiticide Medicines Market Dynamics
  1. 2.1 Pets Parasiticide Medicines Industry Trends
  2. 2.2 Pets Parasiticide Medicines Industry Drivers
  3. 2.3 Pets Parasiticide Medicines Industry Opportunities and Challenges
  4. 2.4 Pets Parasiticide Medicines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pets Parasiticide Medicines Market Perspective (2021-2032)
  2. 3.2 Global Pets Parasiticide Medicines Growth Trends by Region
  3. 3.2.1 Global Pets Parasiticide Medicines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pets Parasiticide Medicines Market Size by Region (2021-2026)
  5. 3.2.3 Global Pets Parasiticide Medicines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pets Parasiticide Medicines Revenue by Players
  2. 4.1.1 Global Pets Parasiticide Medicines Revenue by Players (2021-2026)
  3. 4.1.2 Global Pets Parasiticide Medicines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pets Parasiticide Medicines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pets Parasiticide Medicines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pets Parasiticide Medicines Key Players Headquarters & Area Served
  7. 4.4 Global Pets Parasiticide Medicines Players, Product Type & Application
  8. 4.5 Global Pets Parasiticide Medicines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pets Parasiticide Medicines Market CR5 and HHI
  11. 4.6.3 2025 Pets Parasiticide Medicines Tier 1, Tier 2, and Tier 3
5 Pets Parasiticide Medicines Market Size by Type
  1. 5.1 Global Pets Parasiticide Medicines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pets Parasiticide Medicines Revenue by Type (2021-2032)
  3. 5.3 Global Pets Parasiticide Medicines Revenue Market Share by Type (2021-2032)
6 Pets Parasiticide Medicines Market Size by Application
  1. 6.1 Global Pets Parasiticide Medicines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pets Parasiticide Medicines Revenue by Application (2021-2032)
  3. 6.3 Global Pets Parasiticide Medicines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bimeda Animal Health
  2. 7.1.1 Bimeda Animal Health Company Information
  3. 7.1.2 Bimeda Animal Health Business Overview
  4. 7.1.3 Bimeda Animal Health Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bimeda Animal Health Pets Parasiticide Medicines Product Portfolio
  6. 7.1.5 Bimeda Animal Health Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Pets Parasiticide Medicines Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 Ceva Sante Animale
  14. 7.3.1 Ceva Sante Animale Company Information
  15. 7.3.2 Ceva Sante Animale Business Overview
  16. 7.3.3 Ceva Sante Animale Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Ceva Sante Animale Pets Parasiticide Medicines Product Portfolio
  18. 7.3.5 Ceva Sante Animale Recent Developments
  19. 7.4 Elanco
  20. 7.4.1 Elanco Company Information
  21. 7.4.2 Elanco Business Overview
  22. 7.4.3 Elanco Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Elanco Pets Parasiticide Medicines Product Portfolio
  24. 7.4.5 Elanco Recent Developments
  25. 7.5 Vetoquinol
  26. 7.5.1 Vetoquinol Company Information
  27. 7.5.2 Vetoquinol Business Overview
  28. 7.5.3 Vetoquinol Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Vetoquinol Pets Parasiticide Medicines Product Portfolio
  30. 7.5.5 Vetoquinol Recent Developments
  31. 7.6 Virbac
  32. 7.6.1 Virbac Company Information
  33. 7.6.2 Virbac Business Overview
  34. 7.6.3 Virbac Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Virbac Pets Parasiticide Medicines Product Portfolio
  36. 7.6.5 Virbac Recent Developments
  37. 7.7 Zoetis
  38. 7.7.1 Zoetis Company Information
  39. 7.7.2 Zoetis Business Overview
  40. 7.7.3 Zoetis Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Zoetis Pets Parasiticide Medicines Product Portfolio
  42. 7.7.5 Zoetis Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Pets Parasiticide Medicines Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Merck Pets Parasiticide Medicines Product Portfolio
  54. 7.9.5 Merck Recent Developments
8 North America
  1. 8.1 North America Pets Parasiticide Medicines Revenue (2021-2032)
  2. 8.2 North America Pets Parasiticide Medicines Revenue by Type (2021-2032)
  3. 8.2.1 North America Pets Parasiticide Medicines Revenue by Type (2021-2026)
  4. 8.2.2 North America Pets Parasiticide Medicines Revenue by Type (2027-2032)
  5. 8.3 North America Pets Parasiticide Medicines Revenue Share by Type (2021-2032)
  6. 8.4 North America Pets Parasiticide Medicines Revenue by Application (2021-2032)
  7. 8.4.1 North America Pets Parasiticide Medicines Revenue by Application (2021-2026)
  8. 8.4.2 North America Pets Parasiticide Medicines Revenue by Application (2027-2032)
  9. 8.5 North America Pets Parasiticide Medicines Revenue Share by Application (2021-2032)
  10. 8.6 North America Pets Parasiticide Medicines Revenue by Country
  11. 8.6.1 North America Pets Parasiticide Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pets Parasiticide Medicines Revenue by Country (2021-2026)
  13. 8.6.3 North America Pets Parasiticide Medicines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Pets Parasiticide Medicines Revenue (2021-2032)
  2. 9.2 Europe Pets Parasiticide Medicines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pets Parasiticide Medicines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pets Parasiticide Medicines Revenue by Type (2027-2032)
  5. 9.3 Europe Pets Parasiticide Medicines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pets Parasiticide Medicines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pets Parasiticide Medicines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pets Parasiticide Medicines Revenue by Application (2027-2032)
  9. 9.5 Europe Pets Parasiticide Medicines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pets Parasiticide Medicines Revenue by Country
  11. 9.6.1 Europe Pets Parasiticide Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pets Parasiticide Medicines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pets Parasiticide Medicines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Pets Parasiticide Medicines Revenue (2021-2032)
  2. 10.2 China Pets Parasiticide Medicines Revenue by Type (2021-2032)
  3. 10.2.1 China Pets Parasiticide Medicines Revenue by Type (2021-2026)
  4. 10.2.2 China Pets Parasiticide Medicines Revenue by Type (2027-2032)
  5. 10.3 China Pets Parasiticide Medicines Revenue Share by Type (2021-2032)
  6. 10.4 China Pets Parasiticide Medicines Revenue by Application (2021-2032)
  7. 10.4.1 China Pets Parasiticide Medicines Revenue by Application (2021-2026)
  8. 10.4.2 China Pets Parasiticide Medicines Revenue by Application (2027-2032)
  9. 10.5 China Pets Parasiticide Medicines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pets Parasiticide Medicines Revenue (2021-2032)
  2. 11.2 Asia Pets Parasiticide Medicines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pets Parasiticide Medicines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pets Parasiticide Medicines Revenue by Type (2027-2032)
  5. 11.3 Asia Pets Parasiticide Medicines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pets Parasiticide Medicines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pets Parasiticide Medicines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pets Parasiticide Medicines Revenue by Application (2027-2032)
  9. 11.5 Asia Pets Parasiticide Medicines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pets Parasiticide Medicines Revenue by Country
  11. 11.6.1 Asia Pets Parasiticide Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pets Parasiticide Medicines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pets Parasiticide Medicines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pets Parasiticide Medicines Revenue (2021-2032)
  2. 12.2 SAMEA Pets Parasiticide Medicines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pets Parasiticide Medicines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pets Parasiticide Medicines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pets Parasiticide Medicines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pets Parasiticide Medicines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pets Parasiticide Medicines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pets Parasiticide Medicines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pets Parasiticide Medicines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pets Parasiticide Medicines Revenue by Country
  11. 12.6.1 SAMEA Pets Parasiticide Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pets Parasiticide Medicines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pets Parasiticide Medicines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst